Entyvio 300 mg powder for concentrate for solution for infusion

Active Ingredient
Strength
  • Vedolizumab: 300 mg
Dosage Form
Pdr/Conc/Soln for Infusion
Legal Category
A - prescription, may not be renewed
Last Updated
25/09/2026
SPC section shown.

Loading the document

Takeda Products Ireland Ltd

5 Riverwalk Citywest Business Campus Dublin 24, D24 Dublin

Telephone
+3531800937970